Home  » Topic


Stocks of Wockhardt Declines By 8% Post-Bleak Financial Results
Wockhardt - the global pharmaceutical and biotechnology organization's stock has dipped by 8 percent after the company announced its financial results. The company reported its fourth quarter and fiscal 2018 results on Friday, May 4, 2018. Based on the financial ...
Stocks Wockhardt Declines Post Bleak Financial Results

Why Pharma Shares Are Not A Great Buy?
If there are two sectors that are highly over priced, it is the pharma and FMCG sector. The rationale and logic for such high valuations in the pharma sector is difficult to...
Wockhardt slips over 3% on USFDA scanner
Shares of Wockhardt fell over 3 per cent in early trade on Bombay Stock Exchange (BSE) after media reports said that the US regulator has identified deficiencies in quality,...
Wockhardt Ltd. - News Clarification
The exchange had sought clarification from Wockhardt Ltd. with respect to news item captioned "USFDA raises concern over Wockhardt plant". The Company has clarified that "In...
Wockhardt News Clarification
Wockhardt Q4 net dips 78% to 74.45 cr
Drugmaker Wockhardt Ltd has reported 78 per cent plunge in the consolidated net profit at Rs 74.45 crore for the quarter ended March 31, 2014, mainly due to regulatory issue...
Wockhardt Q4 Net Dips Cr

Get Latest News alerts from Goodreturns

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more